New drug improves treatment of heart failure

In a huge international study, an experimental drug for heart failure worked significantly better than the current backbone of treatment, paving the way for the biggest therapeutic advance in decades.

Novartis’ twice-a-day pill, still known by its code name LCZ696, reduced deaths, hospitalizations, and disabling symptoms of heart failure. It also had fewer serious side effects than the standard therapy, a blood-pressure-lowering medication called enalapril.

“We designed this study to try to change the cornerstone of treatment — to replace enalapril,” said the study’s lead co-author, Milton Packer, a cardiologist and heart failure researcher at University of Texas Southwestern Medical Center. “The results are not only compelling, but exceeded our expectations.”

In an editorial accompanying the study, published online Saturday in the New England Journal of Medicine, University of Pennsylvania cardiologist Mariell Jessup, wrote that the novel therapy may “represent a new threshold of hope for patients with heart failure.”

Heart failure, the only cardiovascular disease on the rise, affects 5 million people in the U.S.

A progressive disorder, it begins when heart cells are injured by a heart attack, infection, chemotherapy, or other causes. Healthy cells try to compensate by overworking and enlarging, while the body retains water and increases blood pressure in a futile effort to improve blood flow.

Until the 1980s, the standard treatments — digoxin, which strengthens heart contractions, and diuretics, which increase urine output — did nothing to reduce mortality, and little to relieve the symptoms of breathlessness, fatigue and swelling.

Then came enalapril, approved in 1985, the first in a class of drugs called ACE inhibitors. These compounds, which lower blood pressure by widening the blood vessels, improved symptoms and survival. Further progress was made by combining ACE inhibitors with drugs that block adrenaline, as well as more sophisticated diuretics.

Even with all this and more — heart failure patients typically take four to eight drugs — about 50 percent die within five years.

The latest advance involves blocking an enzyme, neprilysin, that plays a key role in the complex process of blood vessel constriction, fluid retention, and heart enlargement that makes the heart gradually fail.

“This is a new pathway. That’s what’s really exciting,” Jessup said, adding that other pharmaceutical companies are developing their own anti-neprilysin compounds.

Novartis’ new drug combines its neprilysin inhibitor with valsartan, a blood pressure-lowering drug that works somewhat differently from enalapril.

The pivotal study, begun in 2009, enrolled 8,400 patients with mild to moderately severe heart failure at more than 1,000 centers around the world, making it the largest clinical trial in heart failure ever undertaken. The patients were randomly assigned to take LCZ696 or enalapril, plus other medications that were part of their prescribed regimen.

The trial was stopped early, after following patients for a median of 27 months, because the new drug met criteria for “overwhelming benefit.”

Of 4,187 patients on the new drug, 914 died from cardiovascular causes or were hospitalized for worsening heart failure — 21.8 percent of the group. That compared with 1,117 deaths and hospitalizations (26.5 percent) among 4,212 people taking enalapril.

The Novartis drug was also better tolerated. Slightly less than 11 percent quit it because of side effects such as dangerously low blood pressure or worsening kidney function, compared with about 12 percent for enalapril.

On a questionnaire, patients taking LCZ696 reported more improvement in heart failure symptoms and physical limitations than the comparison group.

Novartis will now ask the U.S. Food and Drug Administration to approve the drug based on the results.

Talk to us

> Give us your news tips.

> Send us a letter to the editor.

> More Herald contact information.

More in Local News

Traffic idles while waiting for the lights to change along 33rd Avenue West on Tuesday, April 2, 2024 in Lynnwood, Washington. (Olivia Vanni / The Herald)
Lynnwood seeks solutions to Costco traffic boondoggle

Let’s take a look at the troublesome intersection of 33rd Avenue W and 30th Place W, as Lynnwood weighs options for better traffic flow.

A memorial with small gifts surrounded a utility pole with a photograph of Ariel Garcia at the corner of Alpine Drive and Vesper Drive ion Wednesday, April 10, 2024 in Everett, Washington. (Olivia Vanni / The Herald)
Death of Everett boy, 4, spurs questions over lack of Amber Alert

Local police and court authorities were reluctant to address some key questions, when asked by a Daily Herald reporter this week.

The new Amazon fulfillment center under construction along 172nd Street NE in Arlington, just south of Arlington Municipal Airport. (Chuck Taylor / The Herald) 20210708
Frito-Lay leases massive building at Marysville business park

The company will move next door to Tesla and occupy a 300,0000-square-foot building at the Marysville business park.

Logo for news use featuring the municipality of Snohomish in Snohomish County, Washington. 220118
1 dead in motorcycle crash on Highway 522 in Maltby

Authorities didn’t have any immediate details about the crash that fully blocked the highway Friday afternoon.

A memorial with small gifts surrounded a utility pole with a photograph of Ariel Garcia at the corner of Alpine Drive and Vesper Drive ion Wednesday, April 10, 2024 in Everett, Washington. (Olivia Vanni / The Herald)
Everett mom charged with first-degree murder in death of son, 4

On Friday, prosecutors charged Janet Garcia, 27, three weeks after Ariel Garcia went missing from an Everett apartment.

Dr. Mary Templeton (Photo provided by Lake Stevens School District)
Lake Stevens selects new school superintendent

Mary Templeton, who holds the top job in the Washougal School District, will take over from Ken Collins this summer.

A closed road at the Heather Lake Trail parking lot along the Mountain Loop Highway in Snohomish County, Washington on Wednesday, July 20, 2023. (Annie Barker / The Herald)
Mountain Loop Highway partially reopens Friday

Closed since December, part of the route to some of the region’s best hikes remains closed due to construction.

Emma Dilemma, a makeup artist and bikini barista for the last year and a half, serves a drink to a customer while dressed as Lily Munster Tuesday, Oct. 25, 2022, at XO Espresso on 41st Street in Everett, Washington. (Ryan Berry / The Herald)
After long legal battle, Everett rewrites bikini barista dress code

Employees now have to follow the same lewd conduct laws as everyone else, after a judge ruled the old dress code unconstitutional.

The oldest known meteor shower, Lyrid, will be falling across the skies in mid- to late April 2024. (Photo courtesy of Pixabay)
Clouds to dampen Lyrid meteor shower views in Western Washington

Forecasters expect a storm will obstruct peak viewing Sunday. Locals’ best chance at viewing could be on the coast. Or east.

AquaSox's Travis Kuhn and Emerald's Ryan Jensen an hour after the game between the two teams on Sunday continue standing in salute to the National Anthem at Funko Field on Sunday, Aug. 25, 2019 in Everett, Wash. (Olivia Vanni / The Herald)
New AquaSox stadium downtown could cost up to $120M

That’s $40 million more than an earlier estimate. Alternatively, remodeling Funko Field could cost nearly $70 million.

Downtown Everett, looking east-southeast. (Chuck Taylor / The Herald) 20191022
5 key takeaways from hearing on Everett property tax increase

Next week, City Council members will narrow down the levy rates they may put to voters on the August ballot.

Everett police officers on the scene of a single-vehicle collision on Evergreen Way and Olivia Park Road Wednesday, July 5, 2023 in Everett, Washington. (Photo provided by Everett Police Department)
Everett man gets 3 years for driving high on fentanyl, killing passenger

In July, Hunter Gidney crashed into a traffic pole on Evergreen Way. A passenger, Drew Hallam, died at the scene.

Support local journalism

If you value local news, make a gift now to support the trusted journalism you get in The Daily Herald. Donations processed in this system are not tax deductible.